Clinical stage pharmaceutical company

Home
About Us
Scientific Approach
- Immunoregulatory and Regenerative Therapy
- Publications
Pipeline
News
Contact Us

Posts classified under: General

MedRegen LLC → General

Search for:

Categories

Medregen 10

Archives

October 2024
September 2024
May 2024
December 2023
September 2023
August 2023
December 2021
May 2021
February 2021
December 2020

MedRegen is a clinical stage pharmaceutical company developing novel therapeutics for the treatment of different types of organ and tissue injury.

Useful Links

Pipeline
Publications
News
About Us
Contact Us

RECENT POST

Phase II ARDS IND Submission China (NMPA) October 30, 2024
Phase II Wound Healing Study Completed September 14, 2024
FDA Phase II IND Approval (ARDS) May 3, 2024

© 2024 MedRegen LLC. All rights reserved.

Privacy Policy
Terms of Use

Seraphinite Accelerator

Optimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.